DMITRI ALEKSENKO, M.D.
Student in an Organized Health Care Education/Training Program in SHREVEPORT, Louisiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
DMITRI ALEKSENKO, M.D. reported a CMS MIPS final score of 63.1724/100 — below the 83.1 national average — and filed 1,755 Medicare Part D claims in 2023.
- 63.1724/100
- MIPS score · -20 vs avg
- 2K
- Part D claims, 2023
- 94%
- generic prescribing
- $49.56
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
DMITRI ALEKSENKO, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
63 6th percentile higher than 6% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about DMITRI ALEKSENKO, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Louisiana
How Student in an Organized Health Care Education/Training Program compares to other specialties among Louisiana providers
Student in an Organized Health Care Education/Training Program share within Louisiana
Student in an Organized Health Care Education/Training Program is one of the more visible NUCC categories in Louisiana
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
DMITRI ALEKSENKO, M.D.'s 2023 MIPS final score plotted against the Student in an Organized Health Care Education/Training Program national average
- MIPS Final Score
- 63.1724/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Student in an Organized Health Care Education/Training Program) — 63.1724/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Student in an Organized Health Care Education/Training Program US NPIs
63.1724/100 MIPS final score — 19.9 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Student in an Organized Health Care Education/Training Program. Quality dim: 80.6287.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
DMITRI ALEKSENKO, M.D. appears in the CMS NPPES registry as a Student in an Organized Health Care Education/Training Program provider holding M.D. credentials at 1811 E BERT KOUNS INDUSTRIAL LOOP, SHREVEPORT, LA, 71105, with a listed phone of (318) 212-2720. NPI 1255718946 was issued on 05/01/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ALEKSENKO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,755 prescription claims written by this provider, covering 297 Medicare beneficiaries and totaling roughly $195K in drug spend, split 6% brand-name and 94% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 63.1724/100 for the 2023 performance year (Quality 80.6287), compared with the national average of 83.1.
Student in an Organized Health Care Education/Training Program is a high-volume specialty nationwide, with 331,761 enrolled providers across 55 states and an average of 459 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1255718946 |
|---|---|
| Specialty | Student in an Organized Health Care Education/Training Program |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 05/01/2015 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm DMITRI ALEKSENKO, M.D.'s current license status, disciplinary history, and board certifications with the Louisiana State Board of Medical Examiners in Louisiana before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DMITRI ALEKSENKO, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$50
Largest payer
TG Therapeutics, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
6% brand-name claims vs 94% generic, on 1,755 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 3,014
- Total Day Supply
- 88,800
- Brand vs Generic
- 6% brand / 94% generic
- Brand Drug Cost
- $116K
- Generic Drug Cost
- $79K
Patient Demographics
- Average Patient Age
- 73.9 years
- Avg HCC Risk Score
- 1.40
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 29, 65-74: 118, 75-84: 123, 85+: 27
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What DMITRI ALEKSENKO, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Donepezil Hcl
Donepezil Hcl
246 claims
- Carbidopa-Levodopa
Carbidopa-Levodopa
173 claims
- Nortriptyline Hcl 94
Nortriptyline Hcl
94 claims
- Memantine Hcl 93
Memantine Hcl
93 claims
- Primidone 92
Primidone
92 claims
- Levetiracetam 85
Levetiracetam
85 claims
- Propranolol Hcl 76
Propranolol Hcl
76 claims
- Gabapentin 75
Gabapentin
75 claims
| Drug | Claims |
|---|---|
| Donepezil Hcl | 246 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 173 |
| Nortriptyline Hcl | 94 |
| Memantine Hcl | 93 |
| Primidone | 92 |
| Levetiracetam | 85 |
| Propranolol Hcl | 76 |
| Gabapentin | 75 |
| Topiramate | 69 |
| Rivastigmine | 53 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Student in an Organized Health Care Education/Training Program Overview
How DMITRI ALEKSENKO, M.D. fits within the Student in an Organized Health Care Education/Training Program landscape nationally.
DMITRI ALEKSENKO, M.D.'s 1,755 claims are above the specialty average of 459.
Nearby Student in an Organized Health Care Education/Training Program Providers in Louisiana
Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as ALEKSENKO.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Louisiana
Frequently Asked Questions
What is DMITRI ALEKSENKO, M.D.'s specialty? ▼
How much does DMITRI ALEKSENKO, M.D. prescribe under Medicare Part D? ▼
What is DMITRI ALEKSENKO, M.D.'s Medicare quality score? ▼
Where is DMITRI ALEKSENKO, M.D. located? ▼
What is DMITRI ALEKSENKO, M.D.'s NPI number? ▼
Does DMITRI ALEKSENKO, M.D. prescribe more brand-name or generic drugs? ▼
How many Student in an Organized Health Care Education/Training Program providers are there in the US? ▼
What drugs does DMITRI ALEKSENKO, M.D. prescribe most often? ▼
Does DMITRI ALEKSENKO, M.D. accept Medicare? ▼
How can I verify DMITRI ALEKSENKO, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology